Abdullah Omar Aldhfyan

Dr. Aldhfyan is a Postdoctoral Fellow with expertise in chemically induced carcinogenesis, focusing on the role of the Aryl Hydrocarbon Receptor (AhR)/CYP1A1 signaling pathway in tumour initiation, progression, and therapeutic resistance. His research interests include cancer stem cell biology, molecular mechanisms driving cancer plasticity, and the identification of novel therapeutic vulnerabilities.

Pharmacology

Chemically-induced carcinogenesis

Cancer stem cells

Therapy resistance

Drug discovery

Xenobiotics

Dr. Aldhfyan is a pharmacology researcher who began their career as a research technician at KFSHRC in 2009, earned a Master’s degree in Pharmacology and Toxicology in 2013, and completed a PhD in Pharmacology focusing on the AhR/CYP1A1 signaling pathway and xenobiotic-related carcinogenesis.